$91.12
+1.26 (+1.40%)
At Close: Jun 03, 2026
Crashed business events to cost economy $35.7b
02:01pm, Thursday, 23'rd Apr 2020
At least $35 billion has been wiped off the economy from the cancellation of business conferences alone. Lifting restrictions is unlikely to help this year.
Zacks Investment Research Lowers Iradimed (NASDAQ:IRMD) to Hold
07:00am, Friday, 17'th Apr 2020
Iradimed (NASDAQ:IRMD) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, Zacks.com reports. According to Zack
Iradimed (NASDAQ:IRMD) Lifted to Buy at ValuEngine
05:48am, Friday, 17'th Apr 2020
Iradimed (NASDAQ:IRMD) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a report issued on Friday, ValuEngine reports. A number of other research analysts have also comment
IRADIMED CORPORATION to Hold 2020 First Quarter Financial Results Conference Call on April 30th
11:00am, Thursday, 16'th Apr 2020
WINTER SPRINGS, Fla., April 16, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 first quarter financial results before.
IRADIMED CORPORATION to Hold —…—… First Quarter Financial Results Conference Call on ...
12:00am, Thursday, 16'th Apr 2020Iradimed (IRMD) - Research Analysts' Recent Ratings Updates
01:20pm, Monday, 13'th Apr 2020
Iradimed (NASDAQ: IRMD) has recently received a number of price target changes and ratings updates: 4/3/2020 – Iradimed was downgraded by analysts at ValuEngine from a “buy” rating to a “hold�
IRADIMED CORPORATION Sees Prelim. Q1 Sales $8.6M-$8.7M, Withdraws 2020 Financial Guidance
11:11am, Tuesday, 07'th Apr 2020IRADIMED CORPORATION Withdraws 2020 Financial Guidance Due to Uncertainties from the Effects of COVID-19
11:00am, Tuesday, 07'th Apr 2020
IRADIMED CORPORATION (IRMD) announced that it expects to report first quarter 2020 revenue of $8.6 million to $8.7 million and is withdrawing its first quarter and full year 2020 financial guidance d
IRADIMED CORPORATION Withdraws —…—… Financial Guidance Due to Uncertainties from the ...
12:00am, Tuesday, 07'th Apr 2020Iradimed (NASDAQ:IRMD) Upgraded at Zacks Investment Research
05:34am, Tuesday, 31'st Mar 2020
Iradimed (NASDAQ:IRMD) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday, Zacks.com reports. The firm presently has a $21.
Iradimed (NASDAQ:IRMD) Rating Lowered to Hold at Zacks Investment Research
07:28am, Thursday, 26'th Mar 2020
Iradimed (NASDAQ:IRMD) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday, Zacks.com reports. According to Za
Zacks Investment Research Upgrades Iradimed (NASDAQ:IRMD) to "Buy"
07:00am, Tuesday, 24'th Mar 2020
Iradimed (NASDAQ:IRMD) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday, Zacks.com reports. The brokerage currently has a
Stocks That Hit 52-Week Lows On Monday
02:34pm, Monday, 23'rd Mar 2020
On Monday morning, 720 companies hit new 52-week lows.
Noteworthy Mentions:
The largest company by market cap to set a new 52-week low was Alphabet (NASDAQ: GOOGL)...
How Does IRadimed's (NASDAQ:IRMD) P/E Compare To Its Industry, After The Share Price Drop?
12:18pm, Sunday, 22'nd Mar 2020
To the annoyance of some shareholders, IRadimed (NASDAQ:IRMD) shares are down a considerable 42% in the last month...
Mar 19, 2020 (The Expresswire) --
Global “Magnetic Resonance Imaging (MRI) Equipments Market” Report 2020 is a comprehensive, professional report provides a...
Sign In
Buy IRMD